About – New Day Pharmaceuticals

Meet Our Leadership Team

At the heart of every successful early-stage company is a visionary team with the expertise, experience, and drive to turn innovation into reality.

Together, we are leveraging our collective experience in pharmaceuticals, biotechnology, investment, and commercialization to bring groundbreaking natural therapies to market—quickly, effectively, and at scale.

Michael Ewers

Chief Executive Officer

With 23 years of international healthcare and business leadership, Michael previously served as the CEO of Medella Springs Healthcare and is a former Procter & Gamble executive. His experience in pharmaceutical and OTC healthcare, sales and marketing strategy, and product development guides New Day Pharmaceuticals’ growth strategy.

Alex Day

Chief Investment Officer

Alex is an accomplished investor with extensive experience in biotechnology, pharmaceuticals, and nutraceuticals. He has secured funding for numerous healthcare companies and plays a crucial role in New Day Pharmaceuticals' investment strategy.

Princess Al Qusiemie

Project Manager

Princess oversees product development, operations, and strategic partnerships, ensuring the successful execution of New Day Pharmaceuticals' mission.

Dr. Morgado

Scientific Innovator

Dr. Morgado is the visionary behind DermalGuard™, having dedicated years to researching and refining the botanical extract at its core. His groundbreaking work on plaque psoriasis, burns, and bed sores has laid the foundation for transformative natural therapies.

About New Day Pharmaceuticals

At New Day Pharmaceuticals, we believe in the power of nature and the precision of pharmaceutical science. Our mission is to identify and develop naturally derived therapies that offer safe, effective solutions for a range of health conditions.

Our First Breakthrough

DermalGuard™

Our first product, DermalGuard™, is a botanical-based topical solution initially introduced as a cosmeceutical for plaque psoriasis. Developed from a natural extract pioneered by Dr. Morgado, it has demonstrated remarkable healing benefits. While DermalGuard™ launches as an OTC product, we are concurrently developing a pharmaceutical-grade version to bring prescription-strength relief to those suffering from chronic skin conditions.

At New Day Pharmaceuticals, we are committed to innovation, scientific integrity, and patient well-being. Our goal is to redefine healthcare by making safe, effective, and naturally derived therapies accessible to everyone.